LWL
RYTM icon

Leo Wealth LLC’s Rhythm Pharmaceuticals RYTM Stock Holding History

Leo Wealth LLC’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$269K Sell
3,088
-3,864
-56% -$376K 0.02% 383
2025
Q4 		$744K Sell
6,952
-915
-12% -$97.1K 0.05% 209
2025
Q3 		$794K Sell
7,867
-5,578
-41% -$518K 0.1% 143
2025
Q2 		$850K Sell
13,445
-2,555
-16% -$156K 0.07% 182
2025
Q1 		$848K Buy
+16,000
New +$888K 0.12% 139

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Leo Wealth LLC's RYTM Position: Q1 2026 in Review

Leo Wealth LLC reduced its Rhythm Pharmaceuticals (RYTM) stake by 56% in Q1 2026, selling an estimated $376K and leaving 3,088 shares worth $269K. The position accounts for 0.02% of the portfolio, ranked #383.

Leo Wealth LLC first reported a position in RYTM in Q1 2025 and has held it in 5 quarters since. The position peaked at $850K in Q2 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Leo Wealth LLC held 3,088 shares of Rhythm Pharmaceuticals worth $269K as of Q1 2026.
  • Leo Wealth LLC sold 3,864 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $376K.
  • Rhythm Pharmaceuticals made up 0.02% of Leo Wealth LLC's portfolio in Q1 2026, its #383 holding.
  • Leo Wealth LLC first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Leo Wealth LLC's Rhythm Pharmaceuticals position peaked at $850K in Q2 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.